These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3123277)

  • 21. Increased progesterone/estradiol ratio on the day of HCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormone.
    Ou YC; Lan KC; Chang SY; Kung FT; Huang FJ
    Taiwan J Obstet Gynecol; 2008 Jun; 47(2):168-74. PubMed ID: 18603501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment variables in relation to oocyte maturation: lessons from a clinical micromanipulation-assisted in vitro fertilization program.
    Avrech OM; Goldman GA; Rufas O; Stein A; Amit S; Yoles I; Pinkas H; Fisch B
    J Assist Reprod Genet; 1997 Jul; 14(6):337-42. PubMed ID: 9226513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WITHDRAWN: Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.
    Daya S
    Cochrane Database Syst Rev; 2007 Jul; (1):CD001299. PubMed ID: 17636664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins.
    Awadalla SG; Friedman CI; Chin NW; Dodds W; Park JM; Kim MH
    Fertil Steril; 1987 Nov; 48(5):811-5. PubMed ID: 3117593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective randomized study of the optimum timing of human chorionic gonadotropin administration after pituitary desensitization in in vitro fertilization.
    Tan SL; Balen A; el Hussein E; Mills C; Campbell S; Yovich J; Jacobs HS
    Fertil Steril; 1992 Jun; 57(6):1259-64. PubMed ID: 1601148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    Fertil Steril; 1998 Dec; 70(6):1063-9. PubMed ID: 9848296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization.
    Scott RT; Navot D
    Fertil Steril; 1994 May; 61(5):880-5. PubMed ID: 8174725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the antral follicle count to predict the outcome of assisted reproductive technologies.
    Chang MY; Chiang CH; Hsieh TT; Soong YK; Hsu KH
    Fertil Steril; 1998 Mar; 69(3):505-10. PubMed ID: 9531887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG.
    Smitz J; Devroey P; Braeckmans P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
    Hum Reprod; 1987 May; 2(4):309-14. PubMed ID: 3114314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The abnormally large follicle during controlled ovarian hyperstimulation: management and outcome of the cycle.
    Alam V; Manzur A; Borini A; Asch RH; Balmaceda JP
    Fertil Steril; 1995 Feb; 63(2):361-5. PubMed ID: 7843444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.
    Younis JS; Simon A; Koren R; Dorembus D; Schenker JG; Laufer N
    Fertil Steril; 1992 Sep; 58(3):575-80. PubMed ID: 1387849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    J Assist Reprod Genet; 1998 Nov; 15(10):599-604. PubMed ID: 9866068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
    Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
    Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins.
    Caspi E; Ron-El R; Golan A; Nachum H; Herman A; Soffer Y; Weinraub Z
    Fertil Steril; 1989 Jan; 51(1):95-9. PubMed ID: 2521328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gonadotropin stimulation and in vitro fertilization following selective hypophyseal suppression by LH/RH analogs].
    Lindner C; Braendle W; Bispink L; Lichtenberg V; Bettendorf G
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):490-4. PubMed ID: 3114041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Luteinization to oocyte retrieval delay in women in whom multiple follicular growth was induced as part of an in vitro fertilization/gamete intrafallopian transfer program.
    Gudmundsson J; Fleming R; Jamieson ME; McQueen D; Coutts JR
    Fertil Steril; 1990 Apr; 53(4):735-7. PubMed ID: 2108061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.